QQQ   292.53 (-1.26%)
AAPL   143.95 (-1.36%)
MSFT   244.06 (-1.65%)
META   148.44 (-2.17%)
GOOGL   97.62 (-1.76%)
AMZN   101.01 (-1.20%)
TSLA   173.16 (-2.66%)
NVDA   196.43 (-3.55%)
NIO   12.14 (-4.48%)
BABA   112.63 (-4.86%)
AMD   73.84 (-2.07%)
T   20.05 (+0.50%)
MU   62.19 (-2.63%)
F   13.08 (-1.43%)
CGC   2.90 (-1.02%)
GE   81.96 (-1.53%)
DIS   108.77 (-0.70%)
AMC   5.05 (-8.35%)
PFE   43.67 (-0.27%)
PYPL   80.87 (-1.17%)
NFLX   357.87 (-0.80%)
QQQ   292.53 (-1.26%)
AAPL   143.95 (-1.36%)
MSFT   244.06 (-1.65%)
META   148.44 (-2.17%)
GOOGL   97.62 (-1.76%)
AMZN   101.01 (-1.20%)
TSLA   173.16 (-2.66%)
NVDA   196.43 (-3.55%)
NIO   12.14 (-4.48%)
BABA   112.63 (-4.86%)
AMD   73.84 (-2.07%)
T   20.05 (+0.50%)
MU   62.19 (-2.63%)
F   13.08 (-1.43%)
CGC   2.90 (-1.02%)
GE   81.96 (-1.53%)
DIS   108.77 (-0.70%)
AMC   5.05 (-8.35%)
PFE   43.67 (-0.27%)
PYPL   80.87 (-1.17%)
NFLX   357.87 (-0.80%)
QQQ   292.53 (-1.26%)
AAPL   143.95 (-1.36%)
MSFT   244.06 (-1.65%)
META   148.44 (-2.17%)
GOOGL   97.62 (-1.76%)
AMZN   101.01 (-1.20%)
TSLA   173.16 (-2.66%)
NVDA   196.43 (-3.55%)
NIO   12.14 (-4.48%)
BABA   112.63 (-4.86%)
AMD   73.84 (-2.07%)
T   20.05 (+0.50%)
MU   62.19 (-2.63%)
F   13.08 (-1.43%)
CGC   2.90 (-1.02%)
GE   81.96 (-1.53%)
DIS   108.77 (-0.70%)
AMC   5.05 (-8.35%)
PFE   43.67 (-0.27%)
PYPL   80.87 (-1.17%)
NFLX   357.87 (-0.80%)
QQQ   292.53 (-1.26%)
AAPL   143.95 (-1.36%)
MSFT   244.06 (-1.65%)
META   148.44 (-2.17%)
GOOGL   97.62 (-1.76%)
AMZN   101.01 (-1.20%)
TSLA   173.16 (-2.66%)
NVDA   196.43 (-3.55%)
NIO   12.14 (-4.48%)
BABA   112.63 (-4.86%)
AMD   73.84 (-2.07%)
T   20.05 (+0.50%)
MU   62.19 (-2.63%)
F   13.08 (-1.43%)
CGC   2.90 (-1.02%)
GE   81.96 (-1.53%)
DIS   108.77 (-0.70%)
AMC   5.05 (-8.35%)
PFE   43.67 (-0.27%)
PYPL   80.87 (-1.17%)
NFLX   357.87 (-0.80%)
NYSE:DHR

Danaher - DHR Stock Forecast, Price & News

$263.94
-2.04 (-0.77%)
(As of 01/30/2023 12:25 PM ET)
Add
Compare
Today's Range
$262.73
▼
$266.82
50-Day Range
$252.49
▼
$277.00
52-Week Range
$233.71
▼
$303.82
Volume
523,055 shs
Average Volume
2.88 million shs
Market Capitalization
$192.14 billion
P/E Ratio
27.35
Dividend Yield
0.38%
Price Target
$310.29

Danaher MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.79 Rating Score
Upside/​Downside
17.9% Upside
$310.29 Price Target
Short Interest
Healthy
0.62% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.37
Upright™ Environmental Score
News Sentiment
0.31mentions of Danaher in the last 14 days
Based on 50 Articles This Week
Insider Trading
Selling Shares
$12.65 M Sold Last Quarter
Proj. Earnings Growth
8.56%
From $10.16 to $11.03 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.04 out of 5 stars

Multi-Sector Conglomerates Sector

2nd out of 15 stocks

Process Control Instruments Industry

1st out of 11 stocks

See Top Rated MarketRank™ Stocks Here

DHR stock logo

About Danaher (NYSE:DHR) Stock

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment is composed of analytical instruments, reagents, consumables, software, and services that hospitals, physicians' offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Stock News Headlines

January 16, 2023 | marketbeat.com
General Electric Stock, The Sum of All Parts Strategy is Paying Off (DHR)
Industrial power solutions company General Electric Company (NYSE: GE) stock has climbed over 20% in 2023 as positive sentiment for its restructuring gains
January 29, 2023 | americanbankingnews.com
Jefferies Financial Group Comments on Danaher Co.'s Q1 2023 Earnings (NYSE:DHR)
January 30, 2023 | Investing Trends (Ad)
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
January 28, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) Given New $320.00 Price Target at Cowen
January 28, 2023 | americanbankingnews.com
Analysts Offer Predictions for Danaher Co.'s Q3 2023 Earnings (NYSE:DHR)
January 28, 2023 | americanbankingnews.com
Q1 2023 Earnings Forecast for Danaher Co. Issued By William Blair (NYSE:DHR)
January 27, 2023 | americanbankingnews.com
Danaher Co. Forecasted to Post Q1 2023 Earnings of $2.25 Per Share (NYSE:DHR)
January 27, 2023 | americanbankingnews.com
Danaher Co. (NYSE:DHR) Director Sells $2,222,510.70 in Stock
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
January 26, 2023 | finance.yahoo.com
Danaher Corporation (NYSE:DHR) Q4 2022 Earnings Call Transcript
January 26, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) Price Target Lowered to $309.00 at Robert W. Baird
January 26, 2023 | americanbankingnews.com
Robert W. Baird Increases Danaher (NYSE:DHR) Price Target to $321.00
January 26, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) PT Raised to $290.00 at Barclays
January 26, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) Lifted to "Strong-Buy" at StockNews.com
January 26, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) Sees Unusually-High Trading Volume Following Strong Earnings
January 25, 2023 | finance.yahoo.com
Danaher Full Year 2022 Earnings: Beats Expectations
January 24, 2023 | finance.yahoo.com
Are Danaher Shares Poised for a Rally?
January 24, 2023 | finance.yahoo.com
Danaher (DHR) Q4 Earnings & Revenues Beat, Increase Y/Y
January 24, 2023 | finance.yahoo.com
GE, 3M and Danaher Results Paint Mixed Picture for Industrial Sector
January 24, 2023 | finance.yahoo.com
Danaher Hit After Cutting Covid-Related Revenue From Growth Reports
January 24, 2023 | americanbankingnews.com
Danaher (NYSE:DHR) Posts Earnings Results, Beats Estimates By $0.42 EPS
January 23, 2023 | finance.yahoo.com
HTHIY vs. DHR: Which Stock Is the Better Value Option?
January 23, 2023 | americanbankingnews.com
Danaher (DHR) Set to Announce Quarterly Earnings on Tuesday
January 18, 2023 | finance.yahoo.com
Danaher (DHR) Stock Moves -1.56%: What You Should Know
January 11, 2023 | finance.yahoo.com
Here's Why Hold Strategy is Apt for Danaher (DHR) Stock Now
January 10, 2023 | finance.yahoo.com
Danaher (DHR) Provides Improved Q4 Core Revenue Growth Guidance
January 9, 2023 | finance.yahoo.com
Danaher sees Q4 sales increasing in ‘low-single-digit percent range’
See More Headlines
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Company Calendar

Ex-Dividend for 1/27 Dividend
12/29/2022
Last Earnings
1/24/2023
Dividend Payable
1/27/2023
Dividend Payable
1/27/2023
Today
1/30/2023
Next Earnings (Estimated)
4/20/2023
Fiscal Year End
12/31/2023
Ex-Dividend for 1/27 Dividend
1/01/2100
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Process control instruments
Sub-Industry
Industrial Conglomerates
Sector
Multi-Sector Conglomerates
Current Symbol
NYSE:DHR
CUSIP
23585110
CIK
313616
Web
www.danaher.com
Phone
(202) 828-0850
Fax
202-828-0860
Employees
80,000
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$310.29
High Stock Price Forecast
$340.00
Low Stock Price Forecast
$265.00
Forecasted Upside/Downside
+17.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$9.65
Trailing P/E Ratio
27.35
Forward P/E Ratio
25.98
P/E Growth
2.18
Net Income
$7.21 billion
Net Margins
22.91%
Pretax Margin
26.35%
Return on Equity
17.97%
Return on Assets
9.88%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
1.89
Quick Ratio
1.52

Sales & Book Value

Annual Sales
$31.47 billion
Price / Sales
6.11
Cash Flow
$14.15 per share
Price / Cash Flow
18.65
Book Value
$66.52 per share
Price / Book
3.97

Miscellaneous

Outstanding Shares
727,960,000
Free Float
646,431,000
Market Cap
$192.14 billion
Optionable
Optionable
Beta
0.82

Social Links


Key Executives

  • Rainer M. BlairRainer M. Blair
    President, Chief Executive Officer & Director
  • Matthew R. McGrewMatthew R. McGrew
    Chief Financial Officer & Executive Vice President
  • Jose-Carlos Gutiérrez-Ramos
    Chief Science Officer & Senior Vice President
  • Sadik Kassim
    Chief Technology Officer
  • Brian W. EllisBrian W. Ellis
    Senior Vice President & General Counsel

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













DHR Stock - Frequently Asked Questions

Should I buy or sell Danaher stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DHR shares.
View DHR analyst ratings or view top-rated stocks.

What is Danaher's stock price forecast for 2023?

14 Wall Street analysts have issued twelve-month price objectives for Danaher's stock. Their DHR share price forecasts range from $265.00 to $340.00. On average, they predict the company's stock price to reach $310.29 in the next year. This suggests a possible upside of 16.7% from the stock's current price.
View analysts price targets for DHR or view top-rated stocks among Wall Street analysts.

How have DHR shares performed in 2023?

Danaher's stock was trading at $265.42 at the beginning of the year. Since then, DHR shares have increased by 0.2% and is now trading at $265.98.
View the best growth stocks for 2023 here.

Are investors shorting Danaher?

Danaher saw a increase in short interest in December. As of December 30th, there was short interest totaling 4,190,000 shares, an increase of 26.6% from the December 15th total of 3,310,000 shares. Based on an average daily volume of 2,750,000 shares, the short-interest ratio is presently 1.5 days. Currently, 0.6% of the company's stock are short sold.
View Danaher's Short Interest.

When is Danaher's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 20th 2023.
View our DHR earnings forecast.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) announced its earnings results on Tuesday, January, 24th. The conglomerate reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.46 by $0.41. The conglomerate had revenue of $8.37 billion for the quarter, compared to the consensus estimate of $7.90 billion. Danaher had a net margin of 22.91% and a trailing twelve-month return on equity of 17.97%. Danaher's revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.69 earnings per share.
Read the conference call transcript.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, December 6th. Stockholders of record on Friday, December 30th will be paid a dividend of $0.25 per share on Friday, January 27th. This represents a $1.00 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, December 29th.
Read our dividend analysis for DHR.

Is Danaher a good dividend stock?

Danaher (NYSE:DHR) pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.38%. The company has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 10.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DHR will have a dividend payout ratio of 9.07% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DHR.

What is Rainer M. Blair's approval rating as Danaher's CEO?

27 employees have rated Danaher Chief Executive Officer Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among the company's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of retail and institutional investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (0.16%), Montrusco Bolton Investments Inc. (0.12%), New York State Teachers Retirement System (0.10%), DAVENPORT & Co LLC (0.07%), Fifth Third Bancorp (0.07%) and Natixis Advisors L.P. (0.07%). Insiders that own company stock include Alan G Spoon, Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, Elias A Zerhouni, Georgeann Couchara, Jennifer Honeycutt, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Raymond C Stevens, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends.

How do I buy shares of Danaher?

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $265.98.

How much money does Danaher make?

Danaher (NYSE:DHR) has a market capitalization of $193.62 billion and generates $31.47 billion in revenue each year. The conglomerate earns $6.43 billion in net income (profit) each year or $9.65 on an earnings per share basis.

How many employees does Danaher have?

The company employs 80,000 workers across the globe.

Does Danaher have any subsidiaries?
The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aldevron, Aldevron L.L.C., American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology Suzhou Co. Ltd., Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise China Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd, Beckman Coulter Laboratory Systems Suzhou Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Finance ApS, Biacore International AB, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Canada ULC, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid India Private Limited, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology Guangzhou Co. Ltd., Cytiva Biotechnology Hang Zhou Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, DCHL Holding BV, DH Denmark Holding ApS, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Holdings Germany LLC, DH II Luxembourg Sarl, DH Japan Finance Sarl, DH Switzerland Finance Sarl, DH Technologies Development Pte Ltd., DHCY Limited, DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher China Holdings Ltd., Danaher Finance Company AB, Danaher HK Holdings Ltd., Danaher Medical ApS, Danaher Shanghai Management Co. Ltd., Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Graphics BV, Esko Graphics Inc., Esko Software BV, Fluke, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies Japan KK, Global Life Sciences Technologies Shanghai Co Ltd., Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. Shanghai Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, ID Business Solutions Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Intermountain Life Sciences LLC, Iris International Inc., KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Launchchange Holding Company, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments Singapore Pte Limited, Leica Microsystems, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems UK Limited, Leica Mikrosysteme GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Life Sciences IP Holdings Corporation, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nobel Biocare, OTT Hydromet Corp, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Austar Lifesciences Limited, Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Canada ULC, Pall China Co. Ltd., Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Schweiz GmbH, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, Precision Nanosystems ULC, Radiometer, Radiometer Medical ApS, Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Sedaru Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Skyland Analytics Inc., Sutron, Swift Biosciences Inc., Sybron Dental Specialties, Tektronix, Thomson Industries, Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Vanrx Pharmasystems Inc., Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies Europe B.V., Videojet Technologies GmbH, Videojet Technologies Inc., Videojet Technologies S Pte.Ltd., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..
Read More
How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The official website for the company is www.danaher.com. The conglomerate can be reached via phone at (202) 828-0850, via email at investor.relations@danaher.com, or via fax at 202-828-0860.

This page (NYSE:DHR) was last updated on 1/30/2023 by MarketBeat.com Staff